28 April 2017
Imports of Synthetic Cannabinoids Restricted
The Drug Enforcement Administration has issued an order that temporarily schedules the following six synthetic cannabinoids, along with their optical, positional and geometric isomers, salts and salts of isomers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act.
- methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate
- methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate
- methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate
- methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate
As a result, these substances are subject to the regulatory controls and administrative, civil and criminal sanctions applicable to the manufacture, distribution, reverse distribution, importation, exportation, research, conduct of instructional activities and chemical analysis and possession of schedule I controlled substances. This order entered into force on 10 April and will be in effect for two years, with a possible extension of one year, pending completion of the permanent scheduling process.
According to the DEA, available data and information indicate that these substances have a high potential for abuse, no currently accepted medical use in treatment in the United States and a lack of accepted safety for use under medical supervision.